Results 111 to 120 of about 8,457,541 (229)

POMELO: Medline corpus with manually annotated food-drug interactions

open access: yes, 2017
International audienceWhen patients take more than one medication, they may be at risk of drug interactions, which means that a given drug can cause unexpected effects when taken in combination with other drugs.
Mougin, Fleur   +10 more
core   +1 more source

Dietary patterns as predictors of adverse antidiabetics reactions - A cross-sectional study of polish diabetes sufferers

open access: yesJournal of Education, Health and Sport
Background: Diabetes mellitus (DM) is a multifaceted problem. There is a need to coordinate the diet with pharmacological interventions, because of the possible interaction between the two. The present study aimed to identify  the factors related to the
Kornelia Skoczylas   +2 more
doaj   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Review of drug-food interactions based on medications used by users of a Basic Health Unit in Sarandi, Parana

open access: yesRevista Uningá
Drug-food interactions do exist and occur often in the population, making it difficult for patients to adhere to the proposed treatment, which means the analysis of this problem is essential.
Everton Cristian Alves da Silva   +2 more
doaj   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

KG-DFI: A Prediction of Drug–Food Interactions Based on Knowledge Graph Embedding

open access: yesComputational and Structural Biotechnology Journal
Drug–food interactions (DFIs) can substantially affect patient safety and therapeutic outcomes. However, most existing computational approaches represent foods by decomposing each food into individual constituent molecules, which captures only limited ...
Mingi Kang, Myoung Jin Lee, Sunyong Yoo
doaj   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein   +7 more
wiley   +1 more source

Staphylococci in Food: Summary Sheet

open access: yes, 1972
Describes staphylococci, their importance, symptoms of staphylococci infection, and how the organism can be destroyed.Previously issued by the U.S.

core  

From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases encompassing axial and peripheral forms, with up to 20% of patients developing symptoms before age 16. Despite this substantial pediatric burden, treatment options for juvenile‐onset SpA (JSpA), particularly those with axial disease (axJSpA), remain limited.
Pamela F. Weiss   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy